Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Promising candidate biomarker of venous thrombosis uncovered

April 30, 2012

U.K. study reveals new potential marker of acute kidney injury in acute on chronic liver failure

April 30, 2012

Phase I trial tests once-daily and intermittent INK-128 dosing

April 27, 2012

Phase I data available on antisense drug for ALS

April 27, 2012

Phase I trial studies vandetanib combination therapy for brain cancer

April 27, 2012

Studies assess GS-9620-induced INF-alpha response and antiviral effects

April 27, 2012

First-in-human data confirm safety of Repligen product for spinal muscular atrophy

April 26, 2012

Abbott research results in new potential analgesics

April 26, 2012

Troponin activator shows promise in patients with ALS

April 26, 2012

Novel data presented on launched antiepileptic at ongoing AAN meeting

April 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...